Clinical Trials in Boston

Showing 1541-1560 of 15,299 trials

Body Acceptance After Baby Intervention

NCT07422571

The purpose of this study is to learn if a novel online single-session intervention can help improve body dissatisfaction in new moms. The active intervention condition, Body Acceptance After Baby (BABI), uses acceptance-based skills to help participants cope with body dissatisfaction. BABI will be evaluated against another active intervention condition (a brief infographic that provides psychoeducation about body image during postpartum) and a waitlist control condition.

Body Dissatisfaction

Northeastern University375 participantsStarted Jan 2026

Boston, Massachusetts, United States

RECRUITINGPhase 1< 1 mile

A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)

NCT07037758

The primary objective for dose exploration and dose expansion is to evaluate the safety and tolerability of tarlatamab in combination with AB248. The primary objective for dose exploration only is to determine the recommended dose for expansion and/or maximum tolerated combination dose (MTCD) of AB248 in combination with tarlatamab.

Extensive Stage Small Cell Lung Cancer

Amgen380 participantsStarted Sep 2025

Los Angeles, California, United States • Tampa, Florida, United States • Atlanta, Georgia, United States +14 more locations

Body Acceptance After Baby Intervention

A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)

Find Trials by Condition in Boston

PReclude Infection EVEnts With No Prophylaxis Transperineal Biopsy 2

Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)

Abemaciclib With or Without Atezolizumab for mCRPC

Zenith® Fenestrated+ Clinical Study

A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

Multisite Implementation of COMPRENDO

Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)

Daily IL-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease

Assessment of Patient Experience With Auto-Captioning Glasses in NF2-Related-Schwannomatosis

Improving Outcomes of Older Adults Undergoing Ostomy Surgery

A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)

Open Pilot Trial Evaluating an Avatar-Guided Intervention for Emerging Adults With Alcohol Use Problems and Suicide Risk

Preliminary Trial of an Avatar Guided Digital Intervention for Emerging Adults

Coformulation of Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab (MK-3475) Monotherapy for Programmed Cell Death 1 Ligand 1 (PD-L1) Positive Metastatic Non-Small Cell Lung Cancer (MK-7684A-003, KEYVIBE-003)

A Phase 2, Open-Label, Extension Study to Evaluate Long Term Safety and Clinical Activity of Briquilimab in Participants From Jasper-Sponsored Chronic Urticaria Trials

A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Infants (0 to <2 Years of Age) With Achondroplasia

A Study to Investigate the Safety, Tolerability and Preliminary Efficacy of NGI226 Microparticles in Patients With Achilles Tendinopathy

[18F]FET PET for Characterization of Progressive or Recurrent Glioma From Treatment Related Changes